These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16007396)

  • 1. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis.
    Kitase A; Hino K; Furutani T; Okuda M; Gondo T; Hidaka I; Hara Y; Yamaguchi Y; Okita K
    J Gastroenterol; 2005 Jun; 40(6):617-24. PubMed ID: 16007396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of malondialdehyde (MDA), 4-hydroxy-2-hexenal (HHE) and 4-hydroxy-2-nonenal (HNE) in fish and fish oil during dynamic gastrointestinal in vitro digestion.
    Larsson K; Harrysson H; Havenaar R; Alminger M; Undeland I
    Food Funct; 2016 Feb; 7(2):1176-87. PubMed ID: 26824872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steatosis in chronic hepatitis C: fuel for overproduction of oxidative stress?
    Koike K
    J Gastroenterol; 2005 Jun; 40(6):664-5. PubMed ID: 16007406
    [No Abstract]   [Full Text] [Related]  

  • 4. Two Toxic Lipid Aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), Accumulate in Patients with Chronic Kidney Disease.
    Soulage CO; Pelletier CC; Florens N; Lemoine S; Dubourg L; Juillard L; Guebre-Egziabher F
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32899405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
    Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
    Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
    Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
    Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
    Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosis.
    Arendt BM; Mohammed SS; Aghdassi E; Prayitno NR; Ma DW; Nguyen A; Guindi M; Sherman M; Heathcote EJ; Allard JP
    J Nutr; 2009 Apr; 139(4):691-5. PubMed ID: 19211827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE..
    Long EK; Picklo MJ
    Free Radic Biol Med; 2010 Jul; 49(1):1-8. PubMed ID: 20353821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
    Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
    Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization.
    Hartley DP; Kolaja KL; Reichard J; Petersen DR
    Toxicol Appl Pharmacol; 1999 Nov; 161(1):23-33. PubMed ID: 10558920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
    Paradis V; Mathurin P; Kollinger M; Imbert-Bismut F; Charlotte F; Piton A; Opolon P; Holstege A; Poynard T; Bedossa P
    J Clin Pathol; 1997 May; 50(5):401-6. PubMed ID: 9215123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells.
    Ishikado A; Nishio Y; Morino K; Ugi S; Kondo H; Makino T; Kashiwagi A; Maegawa H
    Biochem Biophys Res Commun; 2010 Nov; 402(1):99-104. PubMed ID: 20920477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steatosis in chronic hepatitis C: prevalence and predictive factors].
    Ouakaa-Kchaou A; Gargouri D; Kochlef A; Debbiche A; Elloumi H; Ghouma M; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2011 Nov; 89(11):830-6. PubMed ID: 22179918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation.
    Chung FL; Pan J; Choudhury S; Roy R; Hu W; Tang MS
    Mutat Res; 2003 Oct; 531(1-2):25-36. PubMed ID: 14637245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation.
    Long EK; Murphy TC; Leiphon LJ; Watt J; Morrow JD; Milne GL; Howard JR; Picklo MJ
    J Neurochem; 2008 May; 105(3):714-24. PubMed ID: 18194211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner.
    Long EK; Olson DM; Bernlohr DA
    Free Radic Biol Med; 2013 Oct; 63():390-8. PubMed ID: 23726997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional changes in human insulin induced by the lipid peroxidation byproducts 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal.
    Pillon NJ; Vella RE; Souleere L; Becchi M; Lagarde M; Soulage CO
    Chem Res Toxicol; 2011 May; 24(5):752-62. PubMed ID: 21462967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
    Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals.
    Bacot S; Bernoud-Hubac N; Chantegrel B; Deshayes C; Doutheau A; Ponsin G; Lagarde M; Guichardant M
    J Lipid Res; 2007 Apr; 48(4):816-25. PubMed ID: 17220481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.